<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02627222</url>
  </required_header>
  <id_info>
    <org_study_id>CASSAVITA II</org_study_id>
    <nct_id>NCT02627222</nct_id>
  </id_info>
  <brief_title>The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children</brief_title>
  <acronym>CASSAVITA II</acronym>
  <official_title>The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ibadan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Institute for Tropical Agriculture</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study comprises an open-label randomized controlled trial investigating the efficacy of
      consuming a daily ration of pro-vitamin A biofortified cassava on vitamin A status of
      Nigerian children, aged 3-4 years old (n=200).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The primary objective is to assess the efficacy of daily consumption of
      pro-vitamin A rich cassava during 10 weeks on body retinol pools of 3-4 year old children in
      Nigeria after high-dose vitamin A supplementation. The secondary objectives are: 1) To
      investigate the effect of daily consumption of pro-vitamin A rich cassava on functional
      indicators such as nutritional anaemia and gut integrity; 2) To investigate the effect of
      zinc deficiency and genetic polymorphisms in the Beta-Carotene Oxygenase 1 (BCO1) and related
      genes on the efficacy of pro-vitamin A rich cassava consumption; 3) To compare the skin
      colour in the palm of the hand of each participant with their serum retinol levels using a
      handheld non-invasive spectrophotometer.

      Study design: Open-label (single-blinded) randomized controlled trial with two parallel
      groups Study population: Pre-school children, aged 3-4 years living in Osun State area,
      South-Western Nigeria. Children (n=750) will be screened for eligibility. Out of these, n=250
      will undergo a 4-week run-in phase. n=200 children will be randomly allocated to two
      different treatments: 1) Yellow cassava providing ~50% of the recommended daily allowance
      (RDA) for vitamin A; 2) White cassava.

      Main study parameters/endpoints: The primary outcome is the difference in body retinol pools
      between groups 1 and 2 at the end of intervention. Other outcome measures include: other
      vitamin A status indicators (Î²-carotene, retinol binding protein, transthyretin),
      inflammatory markers, iron status indicators, anthropometrics, gut integrity, and thyroid
      function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body retinol pool</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in body retinol pools between groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anaemia</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in haemoglobin concentration between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut integrity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Difference in gut integrity between groups</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum retinol</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in serum retinol concentration between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Serum betacarotene</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in serum retinol concentration between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Retinol binding protein</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in serum retinol binding protein concentration between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Urinary thiocyanate</measure>
    <time_frame>8 weeks</time_frame>
    <description>Difference in urinary thiocyanate concentration between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Thyroid function indicators</measure>
    <time_frame>10 weeks</time_frame>
    <description>Difference in serum thyroid function indicators between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>Serum zinc</measure>
    <time_frame>Baseline</time_frame>
    <description>Effect modification by baseline zinc deficiency</description>
  </other_outcome>
  <other_outcome>
    <measure>Genetic polymorphisms in the BCO1 gene</measure>
    <time_frame>Baseline</time_frame>
    <description>Effect modification by BCO1 polymorphisms</description>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>Baseline and end of study</time_frame>
    <description>C-reactive protein, alpha glycoprotein</description>
  </other_outcome>
  <other_outcome>
    <measure>Malaria</measure>
    <time_frame>Baseline and end of study</time_frame>
    <description>A-symptomatic malaria</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">176</enrollment>
  <condition>Vitamin A Deficiency</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily consumption of two cassava-based meals prepared with pro-vitamin A rich biofortified cassava</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of two cassava-based meals prepared with common white cassava</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pro-vitamin A biofortified cassava</intervention_name>
    <description>Pro-vitamin A biofortified cassava is the product of international conventional breeding programs (non-GMO) in order to increase the pro-vitamin A content of cassava for improved nutritional intake</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Yellow cassava</other_name>
    <other_name>Biofortified cassava</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>White cassava</intervention_name>
    <description>Conventional white cassava</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Cassava</other_name>
    <other_name>Manihot esculenta</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 36 - 59 months (verified by birth certificates, vaccination cards or other formal
             documentation)

          -  Apparently healthy

          -  Parental informed consent

        Exclusion Criteria:

          -  Frequently absent (&gt;20% of feeding days) during run-in

          -  Children not assenting during blood collections

          -  Signs or history of infectious or systemic diseases (e.g. tuberculosis, sickle cell
             anaemia)

          -  Mental status that is incompatible with the proper conduct of the study

          -  Current participation in other research

          -  Food allergy related to the intervention foods
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>36 Months</minimum_age>
    <maximum_age>59 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alida Melse-Boonstra, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Human Nutrition, Wageningen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Human Nutrition, University of Ibadan</name>
      <address>
        <city>Ibadan</city>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2015</study_first_submitted>
  <study_first_submitted_qc>December 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pro-vitamin A</keyword>
  <keyword>Cassava</keyword>
  <keyword>Vitamin A deficiency</keyword>
  <keyword>Retinol Isotope Dilution</keyword>
  <keyword>Preschool children</keyword>
  <keyword>Nigeria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Beta Carotene</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
    <mesh_term>Provitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

